Nanomedicine and Drug Delivery

Emerging Nano medicine

Currently,the treatment of HIV requires regular oral dosage of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies.Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown.Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle(SDN)technology which can improve drug absorption into the body,reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.